274 related articles for article (PubMed ID: 27155497)
1. Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
Feng H; Segalés J; Fraile L; López-Soria S; Sibila M
Vaccine; 2016 Jun; 34(27):3044-3050. PubMed ID: 27155497
[TBL] [Abstract][Full Text] [Related]
2. Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters.
Fraile L; Sibila M; Nofrarías M; López-Jimenez R; Huerta E; Llorens A; López-Soria S; Pérez D; Segalés J
Vet Microbiol; 2012 Dec; 161(1-2):229-34. PubMed ID: 22858231
[TBL] [Abstract][Full Text] [Related]
3. Virological and serological characterization of vaccinated and non-vaccinated piglet subpopulations coming from vaccinated and non-vaccinated sows.
Fraile L; Segalés J; Ticó G; López-Soria S; Valero O; Nofrarías M; Huerta E; Llorens A; López-Jiménez R; Pérez D; Sibila M
Prev Vet Med; 2015 May; 119(3-4):153-61. PubMed ID: 25748003
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
5. Influence of age on the effectiveness of PCV2 vaccination in piglets with high levels of maternally derived antibodies.
Haake M; Palzer A; Rist B; Weissenbacher-Lang C; Fachinger V; Eggen A; Ritzmann M; Eddicks M
Vet Microbiol; 2014 Jan; 168(2-4):272-80. PubMed ID: 24315042
[TBL] [Abstract][Full Text] [Related]
6. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
7. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three commercial one-dose porcine circovirus type 2 (PCV2) vaccines in a herd with concurrent circulation of PCV2b and mutant PCV2b.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2015 May; 177(1-2):43-52. PubMed ID: 25790733
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
10. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
11. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
[TBL] [Abstract][Full Text] [Related]
12. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
[TBL] [Abstract][Full Text] [Related]
13. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
Oh Y; Seo HW; Park C; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
[TBL] [Abstract][Full Text] [Related]
14. Effect of porcine circovirus type 2 (PCV2) load in serum on average daily weight gain during the postweaning period.
López-Soria S; Sibila M; Nofrarías M; Calsamiglia M; Manzanilla EG; Ramírez-Mendoza H; Mínguez A; Serrano JM; Marín O; Joisel F; Charreyre C; Segalés J
Vet Microbiol; 2014 Dec; 174(3-4):296-301. PubMed ID: 25448444
[TBL] [Abstract][Full Text] [Related]
15. Exploratory field study on the effect of Porcine circovirus 2 (PCV2) sow vaccination on serological, virological and reproductive parameters in a PCV2 subclinically infected sow herd.
Oliver-Ferrando S; Segalés J; López-Soria S; Callén A; Merdy O; Joisel F; Sibila M
BMC Vet Res; 2018 Apr; 14(1):130. PubMed ID: 29661203
[TBL] [Abstract][Full Text] [Related]
16. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cytokine profiles in peripheral blood mononuclear cells between piglets born from Porcine circovirus 2 vaccinated and non-vaccinated sows.
Oliver-Ferrando S; Segalés J; Sibila M; Díaz I
Vet Microbiol; 2018 Feb; 214():148-153. PubMed ID: 29408027
[TBL] [Abstract][Full Text] [Related]
18. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2.
Horlen KP; Dritz SS; Nietfeld JC; Henry SC; Hesse RA; Oberst R; Hays M; Anderson J; Rowland RR
J Am Vet Med Assoc; 2008 Mar; 232(6):906-12. PubMed ID: 18341450
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
[TBL] [Abstract][Full Text] [Related]
20. A comparative efficacy test of 1
Do DT; Tran KDV; Quach AT; Lee D; Chang FC; Wu CP; Tat TN; Chae C
Can J Vet Res; 2021 Apr; 85(2):93-100. PubMed ID: 33883815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]